Aura Biosciences: Highly Derisked Late-Stage Eye Cancer Company
Aura Biosciences(AURA) Seeking Alpha·2024-09-17 16:31I covered Aura Biosciences, Inc. (NASDAQ: AURA ) last year, and just last week, the company presented convincing phase 2 data for lead asset bel-sar as a first-line treatment in early-stage choroidal melanoma. AURA hasAbout the TPT serviceThanks for reading. At the Total Pharma Tracker, we offer the following:-Our Android app and website features a set of tools for DIY investors, including a work-in-progress software where you can enter any ticker and get extensive curated research material. For investors r ...